citric acid, anhydrous has been researched along with dalteparin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowry, SK; Courtney, JM; Gaylor, JD; Lowe, GD; Matata, BM; Sundaram, S; Vienken, J; Wark, S | 1 |
| Baumgartner, I; Demarmels Biasiutti, F; Do, DD; Lämmle, B; Mauron, T; Redondo, M; Wuillemin, WA; Z'Brun, A | 1 |
| Farrell, TP; Hayes, KB; Schneider, DJ; Sobel, BE | 1 |
| Boerma, EC; Kingma, WP; Postma, SR; Van der Voort, PH; Van Roon, EN | 1 |
| Bosman, RJ; Dijksman, LM; Koopmans, M; Oudemans-van Straaten, HM; van der Spoel, JI; van der Voort, PH; Wester, JP; Zandstra, DF | 1 |
| Jonsson, P; Mahmood, D; Stegmayr, BG | 1 |
| Gong, D; Ji, D; Liu, Z; Wu, B; Xu, B; Zhang, K | 1 |
| Atzori, L; Bandino, F; Carta, F; Chuchueva, N; Fanos, V; Lussu, M; Noto, A; Peppi, M; Puxeddu, R | 1 |
| Buter, H; Koopmans, M; van der Voort, PHJ | 1 |
| Mahmood, D; Stegmayr, BG | 1 |
5 trial(s) available for citric acid, anhydrous and dalteparin
| Article | Year |
|---|---|
Safety of citrate based hemofiltration in critically ill patients at high risk for bleeding: a comparison with nadroparin.
Topics: Anticoagulants; Citric Acid; Cohort Studies; Critical Illness; Erythrocyte Transfusion; Hemofiltration; Hemorrhage; Humans; Nadroparin; Prospective Studies; Risk Factors; Safety | 2006 |
Citrate anticoagulation for continuous venovenous hemofiltration.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Citric Acid; Critical Illness; Female; Hemofiltration; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Nadroparin; Safety Management | 2009 |
A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation; Citric Acid; Cross-Over Studies; Dialysis Solutions; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sweden; Tinzaparin; Young Adult | 2013 |
Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration.
Topics: Acute Kidney Injury; Adult; Anticoagulants; Blood Coagulation; Citric Acid; Dalteparin; Female; Hemodialysis Solutions; Hemofiltration; Humans; Male; Middle Aged; Treatment Outcome | 2015 |
Haemodialysis with Tinzaparin Versus Dialysate Citrate as Anticoagulation.
Topics: Aged; Aged, 80 and over; Anticoagulants; C-Reactive Protein; Cholesterol, LDL; Citric Acid; Dialysis Solutions; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Time Factors; Tinzaparin | 2018 |
5 other study(ies) available for citric acid, anhydrous and dalteparin
| Article | Year |
|---|---|
In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents.
Topics: Anticoagulants; Aprotinin; Binding, Competitive; Cellulose; Citrates; Citric Acid; Dalteparin; Factor XII; Fibrinolytic Agents; Hemostatics; Heparin; Hirudins; In Vitro Techniques; Membranes, Artificial; Molecular Weight; Nylons; Recombinant Proteins; Renal Dialysis; Surface Properties | 1995 |
SimpliRED D-dimer assay: comparability of capillary and citrated venous whole blood, between-assay variability, and performance of the test for exclusion of deep vein thrombosis in symptomatic outpatients.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Biomarkers; Blood Specimen Collection; Capillaries; Citric Acid; Evaluation Studies as Topic; Female; Fibrin Fibrinogen Degradation Products; Hemagglutination Tests; Humans; Male; Middle Aged; Nadroparin; Outpatients; Pilot Projects; Predictive Value of Tests; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Thrombophlebitis; Veins | 1998 |
The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
Topics: Adenosine Diphosphate; Adult; Analysis of Variance; Anticoagulants; Aspirin; Chemoprevention; Citric Acid; Collagen; Drug Interactions; Enoxaparin; Factor XIIa; Flow Cytometry; Humans; Male; P-Selectin; Plant Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Trypsin Inhibitors; Zea mays | 1999 |
Metabolomic analysis of urine with Nuclear Magnetic Resonance spectroscopy in patients with idiopathic sudden sensorineural hearing loss: A preliminary study.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Aged; Alanine; Anticoagulants; Audiometry, Pure-Tone; Case-Control Studies; Child; Citric Acid; Cohort Studies; Creatinine; Enoxaparin; Female; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Immunosuppressive Agents; Male; Metabolomics; Methylamines; Middle Aged; Pregnenediones; Prognosis; Prospective Studies; Proton Magnetic Resonance Spectroscopy; Urine; Young Adult | 2017 |
Strong ion difference and CVVH: Different response during nadroparin versus citrate anticoagulation.
Topics: Acute Kidney Injury; Adult; Aged; Anesthesia; Anions; Anticoagulants; APACHE; Blood Coagulation; Citrates; Citric Acid; Critical Illness; Electrolytes; Female; Hemofiltration; Humans; Male; Middle Aged; Nadroparin; Nutritional Support; Prospective Studies; Renal Dialysis; Severity of Illness Index; Sodium Citrate; Thrombolytic Therapy | 2018 |